1101 / 1332
7
What do we know about dose to
pathological nodes?
Pittsburgh, IJROBP 2015:
0% after boost dose of 55Gy
EMBRACE I:
8% at median FUP of 2 years
in patients boosted with a
median dose of 59Gy
Ramlov et al, Acta Oncol, 2015:
limited dose effect for
pathological nodes (~55-
65Gy boosts)
Nodal recurrence in pathological nodes after
boost